The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Calithera Biosciences, Inc. (CALA)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0290

0.0000

(0.00%)

As of 02:27PM EDT. Market open.

Currency in USD

Earnings estimate	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
No. of analysts	0	0	0	0
Avg. Estimate	0	0	0	0
Low estimate	0	0	0	0
High estimate	0	0	0	0
Year ago EPS	-4.8	-3.6	N/A	N/A

Revenue estimate	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
No. of analysts	1	1	1	1
Avg. Estimate	N/A	N/A	N/A	N/A
Low estimate	N/A	N/A	N/A	N/A
High estimate	N/A	N/A	N/A	N/A
Year ago sales	N/A	N/A	9.75M	N/A
Sales growth (year/est)	N/A	N/A	N/A	N/A

Earnings history	30/12/2021	30/03/2022	29/06/2022	29/09/2022
Est. EPS	-4.8	-3.7	-2.65	-1.93
Actual EPS	-4.8	-3.6	-1.59	-2.01
Difference	0	0.1	1.06	-0.08
Surprise %	0.00%	2.70%	40.00%	-4.10%

EPS trend	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
Current estimate	0	0	0	0
7 days ago	-1.49	-0.52	-8.62	-1.35
30 days ago	-1.49	-0.52	-8.62	-1.35
60 days ago	-1.49	-0.52	-8.62	-1.35
90 days ago	-1.49	-0.52	-8.62	-1.35

EPS revisions	Current qtr. (Dec 2022)	Next qtr. (Mar 2023)	Current year (2022)	Next year (2023)
Up last 7 days	N/A	N/A	N/A	N/A
Up last 30 days	N/A	N/A	N/A	N/A
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	N/A	N/A	N/A

Growth estimates	CALA	Industry	Sector(s)	S&P 500
Current qtr.	N/A	N/A	N/A	N/A
Next qtr.	N/A	N/A	N/A	N/A
Current year	N/A	N/A	N/A	N/A
Next year	N/A	N/A	N/A	N/A
Next 5 years (per annum)	75.00%	N/A	N/A	N/A
Past 5 years (per annum)	N/A	N/A	N/A	N/A